Line 37: |
Line 37: |
| |5th | | |5th |
| |- | | |- |
− | | | + | |[[ENDO5:Volunteer Assignments and Opportunities|WHO Classification of Endocrine and Neuroendocrine Tumours]] |
| |5th | | |5th |
| |- | | |- |
− | | | + | |[[MALE5:Volunteer Assignments and Opportunities|WHO Classification of Urinary and Male Genital Tumours]] |
| |5th | | |5th |
| |- | | |- |